Previous studies reported that DNA methylation of promoter sites and hepatocyte nuclear factor (HNF) 3β affect the expression of OATP1B3, providing a mechanism for downregulated OATP1B3 expression in HCC [26, 35, 45]. This evidence concerns the gene SLCO1B3 and hepatocellular carcinoma.